Event Brief
May 4, 2026 at 1:03 PM ET
Health Canada approves second Alzheimer’s drug
By The BriefBrief
Health Canada approved a second drug to slow Alzheimer’s, following approval of lecanemab in October 2025.
WHO: Health Canada
WHAT: Approval of a second Alzheimer’s disease-slowing drug in Canada
WHEN: May 4, 2026 at 12:21 PM ET
WHERE: Canada
WHY: No specific cause was reported.
Reporting from 1 identified publisher for this event.
View all 1 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Science of hantavirus transmission: not known for spread
Adam Taylor
May 4, 2026 at 1:03 PM ET
Peter Thiel backs $1bn ocean data centre start-up
Peter Thiel
May 4, 2026 at 1:03 PM ET
Nigeria faces pushback over reintegration of ex-Boko Haram
Nigeria
May 4, 2026 at 1:03 PM ET
Dubai’s financial hub reputation tested by capital shifts
Dubai
May 4, 2026 at 1:03 PM ET
Page 20916 of 21417
Same format. Every time.
Continue reading — sign in or create a free account with
